Abcam (ABC)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

1,425.00p
   
  • Change Today:
      67.00p
  • 52 Week High: 1,719.00
  • 52 Week Low: 1,149.00
  • Currency: UK Pounds
  • Shares Issued: 226.77m
  • Volume: 326,584
  • Market Cap: 3,231.41m
  • RiskGrade: 134

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (m) Pre-tax (m) EPS Dividend
31-Dec-20 Interim 147.50 13.80 8.20p n/a

Key Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-16 171.67 45.41 22.45p 34.3 2.6 +13% 8.91p 1.2%
30-Jun-17 217.10 51.87 25.66p 37.9 2.7 +14% 10.18p 1.0%
30-Jun-18 233.20 69.10 32.70p 40.8 1.5 +27% 12.00p 0.9%
30-Jun-19 259.90 56.40 32.90p 44.8 44.8 +1% 12.13p 0.8%
30-Jun-20 260.00 8.40 16.70p 79.8 n/a -49% 3.55p 0.3%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-21 301.30 49.26 17.63p 80.8 14.5 +6% n/a 0.0%
30-Jun-22 342.92 63.66 23.04p 61.9 2.0 +31% 1.15p 0.1%

Copyright © 2021 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 34.30 34.30 47.53 1.80

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Abcam Market Data

Currency UK Pounds
Share Price 1,425.00p
Change Today 67.00p
% Change 4.93 %
52 Week High 1,719.00
52 Week Low 1,149.00
Volume 326,584
Shares Issued 226.77m
Market Cap 3,231.41m
RiskGrade 134

Abcam Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
92.71% below the market average92.71% below the market average92.71% below the market average92.71% below the market average92.71% below the market average
92.16% below the sector average92.16% below the sector average92.16% below the sector average92.16% below the sector average92.16% below the sector average
Price Trend
37.78% below the market average37.78% below the market average37.78% below the market average37.78% below the market average37.78% below the market average
27.87% below the sector average27.87% below the sector average27.87% below the sector average27.87% below the sector average27.87% below the sector average
Income
68.81% below the market average68.81% below the market average68.81% below the market average68.81% below the market average68.81% below the market average
63.64% below the sector average63.64% below the sector average63.64% below the sector average63.64% below the sector average63.64% below the sector average
Growth
72.85% below the market average72.85% below the market average72.85% below the market average72.85% below the market average72.85% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 7
Sell 0
Strong Sell 0
Total 9
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Abcam Dividends

  Latest Previous
  Interim Final
Ex-Div 19-Mar-20 07-Nov-19
Paid 17-Apr-20 29-Nov-19
Amount 3.55p 8.58p

Trades for 02-Aug-2021

Time Volume / Share Price
16:35 165,915 @ 1,425.00p
16:29 124 @ 1,426.00p
16:29 40 @ 1,426.00p
16:29 154 @ 1,426.00p
16:29 17 @ 1,426.00p

Abcam Key Personnel

CEO Alan Thomas Hirzel
CFO Michael Baldock

Top of Page